• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组人促红细胞生成素α调节放疗对结直肠癌微血管的影响。

Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels.

作者信息

Ceelen W, Boterberg T, Smeets P, Van Damme N, Demetter P, Zwaenepoel O, Cesteleyn L, Houtmeyers P, Peeters M, Pattyn P

机构信息

Department of Surgery, Ghent University Hospital, Ghent, Belgium.

出版信息

Br J Cancer. 2007 Mar 12;96(5):692-700. doi: 10.1038/sj.bjc.6603568. Epub 2007 Feb 13.

DOI:10.1038/sj.bjc.6603568
PMID:17299396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2360077/
Abstract

Recent data suggest that recombinant human erythropoietin (rhEPO) modulates tumour growth and therapy response. The purpose of the present study was to examine the modulation of radiotherapy (RT) effects on tumour microvessels by rhEPO in a rat colorectal cancer model. Before and after 5 x 5 Gy of RT, dynamic contrast-enhanced -magnetic resonance imaging was performed and endothelial permeability surface product (PS), plasma flow (F), and blood volume (V) were modelled. Imaging was combined with pO(2) measurements, analysis of microvessel density, microvessel diameter, microvessel fractal dimension, and expression of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1 alpha (HIF-1alpha), Bax, and Bcl-2. We found that RT significantly reduced PS and V in control rats, but not in rhEPO-treated rats, whereas F was unaffected by RT. Oxygenation was significantly better in rhEPO-treated animals, and RT induced a heterogeneous reoxygenation in both groups. Microvessel diameter was significantly larger in rhEPO animals, whereas VEGF expression was significantly lower in the rhEPO group. No differences were observed in HIF-1alpha, Bax, or Bcl-2 expression. We conclude that rhEPO results in spatially heterogeneous modulation of RT effects on tumour microvessels. Direct effects of rhEPO on neoplastic endothelium are likely to explain these findings in addition to indirect effects induced by increased oxygenation.

摘要

近期数据表明,重组人促红细胞生成素(rhEPO)可调节肿瘤生长及治疗反应。本研究旨在探讨在大鼠结直肠癌模型中,rhEPO对放疗(RT)作用于肿瘤微血管的调节作用。在5×5 Gy放疗前后,进行动态对比增强磁共振成像,并对内皮通透性表面产物(PS)、血浆流量(F)和血容量(V)进行建模。成像结合pO₂测量、微血管密度分析、微血管直径、微血管分形维数以及血管内皮生长因子(VEGF)、缺氧诱导因子-1α(HIF-1α)、Bax和Bcl-2的表达分析。我们发现,放疗显著降低了对照大鼠的PS和V,但在rhEPO治疗的大鼠中未降低,而F不受放疗影响。rhEPO治疗的动物氧合明显更好,放疗在两组中均诱导了异质性再氧合。rhEPO组动物的微血管直径显著更大,而rhEPO组的VEGF表达显著更低。在HIF-1α、Bax或Bcl-2表达方面未观察到差异。我们得出结论,rhEPO导致放疗对肿瘤微血管的作用在空间上产生异质性调节。除了氧合增加所诱导的间接作用外,rhEPO对肿瘤内皮的直接作用可能解释了这些发现。

相似文献

1
Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels.重组人促红细胞生成素α调节放疗对结直肠癌微血管的影响。
Br J Cancer. 2007 Mar 12;96(5):692-700. doi: 10.1038/sj.bjc.6603568. Epub 2007 Feb 13.
2
Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.缺氧诱导因子-1α和血管内皮生长因子在人大肠癌中的表达水平及意义
Chin Med J (Engl). 2004 Oct;117(10):1541-6.
3
[Relationship of hypoxia-inducible factor 1 alpha (HIF-1alpha) gene expression with vascular endothelial growth factor (VEGF) and microvessel density (MVD) in human colorectal adenoma and adenocarcinoma].[缺氧诱导因子1α(HIF-1α)基因表达与人结肠腺瘤及腺癌中血管内皮生长因子(VEGF)和微血管密度(MVD)的关系]
Ai Zheng. 2003 Nov;22(11):1170-4.
4
Effects and mechanism of recombinant human erythropoietin on the growth of human breast cancer MDA-MB-231 cells in nude mice.重组人促红细胞生成素对裸鼠人乳腺癌MDA-MB-231细胞生长的影响及机制
Pathol Res Pract. 2015 Aug;211(8):570-6. doi: 10.1016/j.prp.2015.04.006. Epub 2015 Apr 24.
5
Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells.促红细胞生成素刺激新生大鼠肠系膜微血管内皮细胞的血管生成。
Pediatr Res. 2002 Apr;51(4):472-8. doi: 10.1203/00006450-200204000-00012.
6
Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models.重组人促红细胞生成素α靶向肿瘤内血管,改善人异种移植模型中的化疗效果。
Cancer Res. 2005 Aug 15;65(16):7186-93. doi: 10.1158/0008-5472.CAN-04-2498.
7
Effect of dutasteride on the expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and microvessel density in rat and human prostate tissue.度他雄胺对大鼠和人前列腺组织中缺氧诱导因子-1α、血管内皮生长因子表达及微血管密度的影响
Scand J Urol Nephrol. 2009;43(6):445-53. doi: 10.3109/00365590903337896.
8
Recombinant human erythropoietin (rhEPO) preconditioning on nuclear factor-kappa B (NF-kB) activation & proinflammatory cytokines induced by myocardial ischaemia-reperfusion.重组人促红细胞生成素(rhEPO)预处理对心肌缺血再灌注诱导的核因子-κB(NF-κB)激活及促炎细胞因子的影响
Indian J Med Res. 2006 Sep;124(3):343-54.
9
[Effects of recombinant human erythropoietin on hypoxia inducible factor-1alpha expression in the retina of rabbits with acute high intraocular pressure].[重组人促红细胞生成素对急性高眼压兔视网膜缺氧诱导因子-1α表达的影响]
Nan Fang Yi Ke Da Xue Xue Bao. 2009 Feb;29(2):271-3.
10
Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro.内源性和外源性促红细胞生成素在体外增强对缺血再灌注损伤的神经保护作用。
J Neurochem. 2006 Feb;96(4):1101-10. doi: 10.1111/j.1471-4159.2005.03597.x. Epub 2006 Jan 17.

引用本文的文献

1
Recombinant human erythropoietin accelerated the proliferation of non-small cell lung cancer cell lines and reduced the expression of VEGF, HIF-1α, and PD-L1 under a simulated hypoxic environment in vitro.重组人促红细胞生成素在体外模拟缺氧环境下可加速非小细胞肺癌细胞系的增殖,并降低血管内皮生长因子(VEGF)、缺氧诱导因子-1α(HIF-1α)和程序性死亡受体配体1(PD-L1)的表达。
Chronic Dis Transl Med. 2022 Mar 31;8(2):124-133. doi: 10.1002/cdt3.12. eCollection 2022 Jun.
2
Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.使用不同分子量的对比剂的动态对比增强(DCE)MRI 评估胰腺肿瘤模型中的新生血管通透性。
MAGMA. 2011 Aug;24(4):225-32. doi: 10.1007/s10334-011-0256-9. Epub 2011 May 13.
3

本文引用的文献

1
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.动态对比增强磁共振成像作为一种成像生物标志物。
J Clin Oncol. 2006 Jul 10;24(20):3293-8. doi: 10.1200/JCO.2006.06.8080.
2
Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study.促红细胞生成素α可提高Ⅲ期食管癌放化疗后的生存率:一项前瞻性观察性研究的最终结果
Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):459-65. doi: 10.1016/j.ijrobp.2005.12.019. Epub 2006 Apr 11.
3
The effect of darbepoetin alfa on growth, oxygenation and radioresponsiveness of a breast adenocarcinoma.
Novel avenues of drug discovery and biomarkers for diabetes mellitus.糖尿病的新药发现途径和生物标志物。
J Clin Pharmacol. 2011 Feb;51(2):128-52. doi: 10.1177/0091270010362904. Epub 2010 Mar 10.
4
Oxidative stress: Biomarkers and novel therapeutic pathways.氧化应激:生物标志物和新的治疗途径。
Exp Gerontol. 2010 Mar;45(3):217-34. doi: 10.1016/j.exger.2010.01.004. Epub 2010 Jan 11.
5
Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology.促红细胞生成素、叉头蛋白与氧化损伤:生物标志物与生物学
ScientificWorldJournal. 2009 Oct 2;9:1072-104. doi: 10.1100/tsw.2009.121.
6
Erythropoietin and oxidative stress.促红细胞生成素与氧化应激
Curr Neurovasc Res. 2008 May;5(2):125-42. doi: 10.2174/156720208784310231.
7
Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies.促红细胞生成素:阐明拓宽治疗策略的新细胞靶点。
Prog Neurobiol. 2008 Jun;85(2):194-213. doi: 10.1016/j.pneurobio.2008.02.002. Epub 2008 Mar 4.
8
Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.三重奏:在糖尿病中利用烟酰胺、WNT和促红细胞生成素促进神经血管长寿
Biomed Pharmacother. 2008 Apr-May;62(4):218-32. doi: 10.1016/j.biopha.2008.01.009. Epub 2008 Feb 20.
9
Raves and risks for erythropoietin.促红细胞生成素的狂热追捧与风险
Cytokine Growth Factor Rev. 2008 Apr;19(2):145-55. doi: 10.1016/j.cytogfr.2008.01.004. Epub 2008 Mar 4.
Radiat Res. 2006 Feb;165(2):192-201. doi: 10.1667/rr3499.1.
4
Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model.小鼠肿瘤模型中辐射后缺氧、增殖和凋亡的动态变化
Radiat Res. 2006 Mar;165(3):326-36. doi: 10.1667/rr3515.1.
5
Magnetic resonance macromolecular agents for monitoring tumor microvessels and angiogenesis inhibition.用于监测肿瘤微血管及抑制血管生成的磁共振大分子造影剂
Invest Radiol. 2006 Mar;41(3):325-31. doi: 10.1097/01.rli.0000186565.21375.88.
6
Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.在结直肠癌肿瘤模型中,使用动态对比增强磁共振成像(DCE-MRI)对放疗引起的微血管变化进行无创监测。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1188-96. doi: 10.1016/j.ijrobp.2005.10.026. Epub 2006 Feb 2.
7
Basic principles and applications of fractal geometry in pathology: a review.分形几何在病理学中的基本原理及应用:综述
Anal Quant Cytol Histol. 2005 Oct;27(5):284-90.
8
Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis.人重组促红细胞生成素(rEpo)对肿瘤生长或血管生成没有影响。
Br J Cancer. 2005 Dec 12;93(12):1350-5. doi: 10.1038/sj.bjc.6602846.
9
Relation of erythropoietin and erythropoietin receptor expression to hypoxia and anemia in head and neck squamous cell carcinoma.促红细胞生成素及促红细胞生成素受体表达与头颈部鳞状细胞癌缺氧和贫血的关系
Clin Cancer Res. 2005 Nov 1;11(21):7614-20. doi: 10.1158/1078-0432.CCR-05-1097.
10
Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas.促红细胞生成素受体不是肿瘤缺氧的替代标志物,与头颈部鳞状细胞癌的生存率无关。
Radiother Oncol. 2005 Aug;76(2):213-8. doi: 10.1016/j.radonc.2005.06.030.